Literature DB >> 32642809

P53 staining index and zonal staining patterns in actinic keratoses.

Sanja Javor1,2, Giulia Gasparini1,2,3, Valerio Gaetano Vellone2,4, Aurora Parodi1,2, Chiara Maria Biatta2,4, Emanuele Cozzani5,6, Francesco Cabiddu2,3, Jean Louis Ravetti2.   

Abstract

Actinic keratoses (AKs) are common dysplastic lesions resulting from chronic excessive ultraviolet exposure. Neither the clinical grade of thickness nor the histological grade of dysplasia seems valid predictors of aggressive potential of AKs. Instead, the mutational status in AKs appears to predict well the clinical course. TP53 gene mutations result in a non-functional protein resistant to degradation, thus immunohistochemical staining for p53 can suggest mutation status. Increased p53 was associated with progression from AK to squamous cell carcinoma. To investigate how the intensity of p53 staining (p53 staining index) varies according to body site, histological subtype and grade dysplasia of AKs. Secondly, we sought to investigate the distribution in the epidermal layers of non-functional p53 (zonal staining patterns). p53 staining index was greater than 50% in 90.7% of AKs. p53 staining index was significantly higher in older age (p < 0.0093) and in facial AKs compared to other body areas (p = 0.03). A significant correlation between p53 staining index and grade of dysplasia was observed (p = 0.006) and between p53 staining index and zonal p53 staining pattern (p = 0.003). No significant differences in p53 staining index among the various histological AK types were observed. No correlation between clinical and histological grade. All AKs, independently from their clinical appearance, should be treated but special attention is required for AKs on severely photodamaged skin on the face and in older patients.

Entities:  

Keywords:  Actinic keratosis; Immunohistochemistry; Non-melanoma skin cancer; Squamous cell carcinoma; p53

Year:  2020        PMID: 32642809     DOI: 10.1007/s00403-020-02104-y

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

1.  The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.

Authors:  Ulker Karagece Yalçin; Selda Seçkın
Journal:  Turk Patoloji Derg       Date:  2012

2.  The clinical course of actinic keratosis correlates with underlying molecular mechanisms.

Authors:  A Bakshi; R Shafi; J Nelson; W C Cantrell; S Subhadarshani; A Andea; M Athar; C A Elmets
Journal:  Br J Dermatol       Date:  2019-09-11       Impact factor: 9.302

3.  Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.

Authors:  J Einspahr; D S Alberts; M Aickin; K Welch; P Bozzo; T Grogan; M Nelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-08       Impact factor: 4.254

4.  The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma.

Authors:  Aaron Fuchs; Ellen Marmur
Journal:  Dermatol Surg       Date:  2007-09       Impact factor: 3.398

5.  Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does gender have a role?

Authors:  S Javor; S Chimenti; A Patrizi; L Stingeni; G Pellacani; S Cavicchini; R Sala; F Rongioletti; A Parodi
Journal:  G Ital Dermatol Venereol       Date:  2014-04       Impact factor: 2.011

Review 6.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

  6 in total
  3 in total

Review 1.  A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.

Authors:  Laura Del Regno; Silvia Catapano; Alessandro Di Stefani; Simone Cappilli; Ketty Peris
Journal:  Am J Clin Dermatol       Date:  2022-02-19       Impact factor: 6.233

Review 2.  Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.

Authors:  Stephenie Droll; Xiaomin Bao
Journal:  Cell Physiol Biochem       Date:  2021-09-22

3.  TP53 Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours.

Authors:  Raquel Martín-Sanz; José María Sayagués; Pilar García-Cano; Mikel Azcue-Mayorga; María Del Carmen Parra-Pérez; María Ángeles Pacios-Pacios; Enric Piqué-Durán; Jorge Feito
Journal:  Dermatopathology (Basel)       Date:  2021-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.